ArticleNeuropsychiatric disease and treatment2026
Diagnosis and Prescribing Patterns of Adult Attention-Deficit Hyperactivity Disorder in a Tertiary Care Hospital in the United Arab Emirates: A Retrospective Study.
Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adult attention-deficit hyperactivity disorder (ADHD) is increasingly recognized; however, evidence describing diagnostic pathways, comorbidity burden, and prescribing practices in adult care remains limited. Purpose: To characterize diagnostic patterns, psychiatric comorbidities, and prescribing practices for adult ADHD across outpatient specialties in a tertiary care setting in the United Arab Emirates.. Methods: A retrospective chart review was conducted for adults aged ≥18 years diagnosed with attention-deficit hyperactivity disorder (ADHD) at a tertiary care hospital in Dubai, United Arab Emirates, between May 2023 and August 2024. Cases were identified using the ICD-10 code F90.x. Demographic characteristics, diagnosing specialty, ADHD diagnostic hierarchy and subtype, psychiatric comorbidities, and prescription data were extracted from electronic health records. Prescription data included ADHD-specific pharmacotherapy and medications for associated psychiatric or medical comorbidities. Descriptive statistics summarized diagnostic and prescribing patterns. One-way analysis of variance and chi-square tests examined differences in diagnostic yield across outpatient specialties and associations between diagnosis type, comorbidity presence, and prescribing patterns, with statistical significance set at P < 0.05. Results: A total of 157 adult ADHD cases were identified. Psychiatry accounted for most diagnoses (60.5%), followed by family medicine (28.0%), neurology (10.2%), and internal medicine (1.3%). Diagnostic yield differed significantly across specialties (F = 32.96, P < 0.001). ADHD was documented as a secondary diagnosis in 60.5% of cases, most commonly with anxiety and depressive disorders, with comorbidity presence significantly associated with diagnosis type (χ Conclusion: Adult ADHD was often diagnosed with psychiatric comorbidity, mainly in psychiatric services, with marked variation across specialties, highlighting the need for standardized diagnostic pathways and UAE-specific clinical guidance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.